Associated Papers
Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.
Rahimi M et al.
Journal of Endocrinological Investigation, 2017
Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts.
Lenz B et al.
Psychopharmacology, 2012
Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.
Li J et al.
American Journal of Epidemiology, 2010
Small effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men.
Bogaert V et al.
European Journal of Endocrinology, 2009
Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
Paz-y-Miño C et al.
Cancer Genetics and Cytogenetics, 2009
Genetic polymorphism and pathogenesis of benign prostatic hyperplasia.
Konwar R et al.
Bju International, 2008
Early diagnosis of 5alpha-reductase deficiency in newborns.
Bertelloni S et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation, 2007
New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.
Hackel C et al.
Journal of Molecular Medicine (berlin, Germany), 2005
Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.
Roberts RO et al.
The Prostate, 2005
Genetic polymorphisms and prostate cancer risk.
Gsur A et al.
World Journal of Urology, 2004
Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer.
Lamharzi N et al.
International Journal of Cancer, 2003
Prostate cancer susceptibility genes: lessons learned and challenges posed.
Simard J et al.
Endocrine-related Cancer, 2003
Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
Azzouzi AR et al.
European Journal of Endocrinology, 2002
Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2002
Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement.
Shibata A et al.
The Journal of Urology, 2001